- Sort by date
- Hybrid Sort
- Sorted by Smart Random Sort
- Sort by relevance
Advertisements
» Related Searches: cancer, breast cancer, lung cancer treatment, cancer risk, drug
Results 21 to 30 of 68 
ENGLAND WON'T GET LUNG DRUG
LUNG cancer sufferers in England are to be denied a drug which is freely
available in Scotland, a health watchdog decided yesterday … 
- ├ Cancer drug guidance dismay — BBC News | UK News | England | World Edition
- ├ Cancer drug guidance concern — BBC News | Health | UK Edition
- ├ Dismay over cancer drug guidance — BBC News | Latest Published Stories | UK Edition
- └ all 10 related »
Drug That Interrupts A Key Stage Of Cell Division Shows …
One of the first studies to investigate the effects of a new anti-cancer drug in
patients with advanced or metastatic solid tumours has shown that it is capable of halting …
- ├ Drug That Interrupts A Key Stage Of … — Health News from Medical News Today
- ├ Enzyme Inhibitor Produces Stable Disease In Patients … — Health News from Medical News Today
- ├ Enzyme Inhibitor Produces Stable Disease In Patients … — Health News from Medical News Today
- └ all 10 related »
Heart Risk Seen in Drug for Anemia
A new study suggests that high doses of a best-selling drug used to treat anemia in
dialysis and cancer patients may increase the risk of heart problems …
NHS bar on lung cancer treatment
An innovative cancer drug has been turned down for use on the NHS, shortening the
lives of thousands of people who could benefit from it …
- ├ Watchdog rules against new treatment for lung … — Guardian Unlimited UK Latest
- ├ Lung cancer top killer among malignant tumors … — KeralaNext: China
- ├ Nab-Paclitaxel and Carboplatin Appear Effective in Lung … — Medscape Hematology-Oncology Headlines
- └ all 10 related »
A vial and pack of Herceptin are seen in London June 9, 2006.
… Drug Administration has agreed to expand the use of Genentech Inc.'s breast
cancer drug Herceptin to include women with early-stage cancer who have
undergone surgery, the company said on Thursday …
Drug switch improves breast cancer survival
LONDON (Reuters) - Switching patients with early breast cancer from a standard
drug to a newer treatment helps them to live longer and improves their odds of
remaining free of …
Synta drug placed on fast track
Synta Pharmaceuticals Corp. said Wednesday that its drug candidate to treat a serious
type of skin cancer has been granted Fast Track designation by the U.S. Food and
Drug Administration …
North American gets FDA approval for breast cancer treatment
North American Scientific Inc. got approval from the Food and Drug Administration to
market a high-dose radiation design of its breast cancer treatment, the company said
Tuesday …
- ├ North American Gets Cancer Treatment OK — FDA News News from StratCenter.com
- ├ North American Scientific Announces FDA Clearance of … — FDA News News from StratCenter.com
- ├ Cancer treatment of black women delayed — United Press International - Consumer Health
- └ all 10 related »
FDA Expands Use of Herceptin for Early Stage Breast Cancer …
The new indication is for Herceptin, in combination with other cancer drugs, for the
treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy) …
Arqule Early Cancer Study Shows Progress
Biotech company Arqule said interim results of an early-stage antitumor drug trial
showed positive results, lifting the company's stock …
- ├ Recurrent breast cancer: Drug shows promise — The Cancer Blog
- ├ A transmission electron micrograph shows a prostate … — Top Stories Photos - Reuters on Yahoo! News Photos
- ├ Novel Vaccine Shows Promise Against Early-stage Breast … — ScienceDaily Headlines
- └ all 10 related »